BEAM · Beam Therapeutics Inc. · Investor Relations
$24.93
+0.74 (+3.06%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$2.58B
Shares
103.29M
Volume · Oct 20
1.48M
Avg daily vol (3M)
1.81M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-10-27 12:00 UTC | BEAM-301 Initial Data Update at ESGCT | Webcast |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-10 | Cantor Fitzgerald Global Healthcare Conference 2026 | Conference |
| 2026-09-09 | Citi's 2026 Biopharma Back to School Conference | Conference |
| 2026-09-08 | Wells Fargo 21st Annual Healthcare Conference | Conference |
| 2026-09-08 | Beam-302 ERS Update | Webcast |
| 2026-05-20 | 2026 RBC Capital Markets Healthcare Conference | Conference |
| 2026-03-25 | BEAM-302 Topline Data Update | Webcast |
| 2026-02-24 | Liver-Targeted Genetic Disease Franchise Update and FY 2025 Earnings | Earnings call |
Source: https://investors.beamtx.com/
Key facts
CIK
1745999
CUSIP
07373V105
13F (30d)
22 filings
22 filers
Visit website
Investor relations